Thomas Nerreter
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 22
- CAR-T cell therapy research 16
- Drug Transport and Resistance Mechanisms 3
- Immunology 11
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Biosimilars and Bioanalytical Methods 2
- Co-authors
- Michael Hudecek (13 shared papers)Hermann Einsele (14 shared papers)Julian Rydzek (4 shared papers)Katrin Mestermann (3 shared papers)Silke Frenz (2 shared papers)Theodoros Giavridis (1 shared paper)Justus Weber (3 shared papers)Andreas Mades (2 shared papers)
- Journals
- Experimental Hematology (2 papers)Journal of Pharmacy & Pharmaceutical Sciences (2 papers)Blood (2 papers)Leukemia (2 papers)Molecular Therapy (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thomas Nerreter
24 papers receiving 1.1k citations
Thomas Nerreter's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 851
- Immunology 305
- Hematology 131
- Genetics 210
- Structural Biology 11
Countries citing papers authored by Thomas Nerreter
This map shows the geographic impact of Thomas Nerreter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nerreter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nerreter more than expected).
Fields of papers citing papers by Thomas Nerreter
This network shows the impact of papers produced by Thomas Nerreter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nerreter. The network helps show where Thomas Nerreter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Nerreter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells Hit paper breakdown → | 2019 | 388 |
| 2 | 2019 | 159 | |
| 3 | 2018 | 154 | |
| 4 | 2019 | 114 | |
| 5 | 2020 | 57 | |
| 6 | 2018 | 42 | |
| 7 | 2020 | 39 | |
| 8 | 2017 | 39 | |
| 9 | 2014 | 25 | |
| 10 | 2022 | 24 | |
| 11 | 2018 | 23 | |
| 12 | 2020 | 17 | |
| 13 | 2014 | 12 | |
| 14 | 2014 | 11 | |
| 15 | 2014 | 9 | |
| 16 | 2025 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2018 | 6 | |
| 19 | 2013 | 5 | |
| 20 | 2017 | 4 |
About Thomas Nerreter
Thomas Nerreter is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Genetics, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Virus-based gene therapy research (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Oncology (851 citations), Immunology (305 citations), Hematology (131 citations), Genetics (210 citations) and Structural Biology (11 citations). Thomas Nerreter has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Hudecek, Hermann Einsele, Julian Rydzek, Katrin Mestermann, Silke Frenz, Theodoros Giavridis, Justus Weber, Andreas Mades, Michel Sadelain and Markus Sauer. Their work appears in journals such as Experimental Hematology, Journal of Pharmacy & Pharmaceutical Sciences, Blood, Leukemia and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.